Regenerative Medical Technology RMTG
OTC RMTG
$0.03 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Regenerative Medical Technology (RMTG) Acquisitions (2020 - 2021)

Updated

Regenerative Medical Technology (RMTG) recorded Acquisitions of -$174,820 in Q4 2021.

Analysis

Regenerative Medical Technology (RMTG) Acquisitions (2020 - 2021) Analysis & Trends

For FY2021, Regenerative Medical Technology reported Acquisitions of -$666,467.

  • Across earlier years, Acquisitions came in at $175,000 in FY2020.
  • The Q4 2021 figure is the highest quarterly Acquisitions since Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 887.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -17.15 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.59 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 630.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Regenerative Medical Technology 412,169.03 -4.11 Mn 2.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -174,820.00
Sep 30, 2021 -741,647.00
Sep 30, 2020 125,000.00
API Access

Regenerative Medical Technology Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=RMTG&period=max&api_key=YOUR_API_KEY